Short-term cardiovascular effects of salmeterol

Chest

Volumn 113, Issue 5, 1998, Pages 1272-1276

  Tranfa, Carmelindo M E ^a,b   Pelaia, Girolamo ^a   Grembiale, Rosa D ^a   Naty, Saverio ^a   Durante, Salvatore ^b   Borrello, Gennarino ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Policlinico Mater Domini   (Italy)

Author keywords

Cardiovascular effects; Holter monitoring; Salmeterol

Indexed keywords

SALMETEROL;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BETA ADRENERGIC STIMULATION; BLOOD PRESSURE MONITORING; CARDIOTOXICITY; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; HYPOKALEMIA; HYPOTENSION; HYPOXEMIA; MALE; PRIORITY JOURNAL; VASODILATATION;

EID: 0031954449     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.5.1272     Document Type: Article

References (14)

1. Crane J, Burgess C, Beasley R. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax 1989; 44:136-40
2. Flatt A, Crane J, Purdie G, et al. The cardiovascular effects of beta adrenergic agonist drugs administered by nebulization. Postgrad Med J 1990; 66:98-101
3. Wong CS, Pavord ID, Williams J. et al. Bronchodilator, cardiovascular and hypokalaemic effects of fenoterol, salbutamol and terbutaline in asthma. Lancet 1990; 336:1396-99
4. Buxton BF. Jones CR, Molenaar P, et al. Characterization and antoradiographic localization of beta adrenoceptor subtypes in human cardiac tissues. Br J Pharmacol 1987; 92:299-310
5. Laursen LC, Tandorf E, Gnospelius Y, et al. Long term oral therapy of asthma with terbutaline and theophylline, alone and combined. Eur J Respir Dis 1985, 66:82-90
6. Nicklas RA, Balzas T. Adverse effects of theophylline beta agonist interactions. J Allergy Clin Immunol 1986; 78:806-11
7. Kung M, Croley SW, Phillips BA. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol: influence of mouth rinsing and gargling. Chest 1987; 91:382-87
8. Wiinter RJD, Langford JA, Rudd RM. Effects of oral and inhaled salbutamol and oral pirbuterol on right and left ventricular function in chronic bronchitis. BMJ 1984; 288: 824-25
9. Kemp JP, Chervski P, Orgel HA, et al. Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoring. J Allergy Clin Immunol 1984; 73(1 Pt 1):32-43
10. Johnson M, Butchers PR, Coleman RA, et al. The pharmacology of salmeterol. Life Sci 1993; 52:2131-43
11. Quanjer Ph H, Tammeling GJ, Cotes JE, et al. Lung volumes and forced expiratory flows. In: Standardized lung function testing. Eur Respir J 1993; 6 (suppl):5-40
12. Britton MG, Earnshaw JS, Palmer JBD. A 12 month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992; 5:1062-67
13. Pearlson DS, Chervinsky P, LaForce C, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992; 327:1420-25
14. Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995; 152:838-60